NNZ-2566

· Neuren Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for NNZ-2566, covering 2012-11-22 to 2020-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of NNZ-2566 in Pediatric Rett Syndrome [Phase 2]